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Abstract: The cornea, the transparent part of the eye that helps in the formation of images, has multiple layers. Among them, the
superficial epithelial layer is protected and maintained homeostatically by the limbus, located in the periphery of the cornea. Limbal
stem cells are located at the basal layer of the limbus and the loss of these cells is called limbal stem cell deficiency (LSCD). LSCD is
characterized by corneal vascularization, inflammation, and conjunctivalization, which ultimately lead to blindness. Several clinical
transplantation procedures used for the treatment of LSCD are cultivated limbal epithelial transplantation, simple limbal epithelial
transplantation, and cultured oral mucosal epithelial transplantation. Long term follow-up of these mentioned transplantations across
the globe shows that the success rate declines as the follow-up period increases. There is an urgent need to know the mechanism of stem
cell transplantation in curing LSCD to improve the success rate of the transplantations. There are numerous reports on other stem cell
transplantation procedures and its mechanism in healing the disease or deficiency. In the case of LSCD a lot of labeling and tracking
methods are used, but there are no confined reports on the mechanisms of the stem cell transplantation and its success. This review
summarizes the current treatments available for LSCD, substrates used during limbal stem cell culture and transplantation, and findings
from posttransplant cell tracking experiments conducted up to date.
Key words: Limbal stem cell deficiency, limbal epithelial transplantation, limbal stem cells, stem cell transplantation, cell tracking,
cornea

1. Introduction
The unique structure of the cornea, the transparent and
curved surface of the eye, grants it powerful refractive
capabilities that are critical for sight. A multilayered
epithelium composes the outermost region of the cornea,
protecting the inner corneal strata and intraocular
structures against infection and injury. The cornea
undergoes orderly desquamation as superficial epithelial
cells are sloughed off and replaced by deeper cells with
complete turnover occurring every 7 days (Bartlett and
Jaanus 2008). Cells of the basal stratum, in conjunction
with limbal stem cells (LSCs) located in the periphery
of the cornea, play a central role in maintaining corneal
epithelial homeostasis.
Current knowledge of the processes governing the
homeostatic maintenance of the corneal epithelium
can be summarized in the following theories: 1) corneal
epithelial stem cell hypothesis (Majo et al., 2008); 2) limbal
epithelial stem cell hypothesis (Lehrer et al., 1998); and 3)
germinative basal layer hypothesis (Haddad and Faria-eSousa, 2014). According to the corneal epithelial stem cell
hypothesis, stem cells scattered throughout the cornea are
responsible for replenishing the epithelium during normal
* Correspondence: santosh.biotech24@gmail.com

homeostasis, while stem cells residing within the limbus
are activated only at the time of wound repair. Conversely,
the limbal stem cell hypothesis states that under normal
conditions, LSCs repopulate the epithelium. These
cells migrate from the limbal crypt at the corneoscleral
junction into the basal corneal epithelium, where they
proliferate and move towards the corneal surface. In the
event of corneal insult, LSCs are stimulated to proliferate
more rapidly. In contrast with the previous models, the
germinative basal layer hypothesis proposes that the cells
of the corneal basal epithelium are responsible for the
renewal of the superficial epithelium, with no significant
involvement of the limbus. Of these competing theories,
the limbal epithelial stem cell hypothesis has been most
favored by experimental evidence (West et al., 2015).
To identify the cell source behind epithelial
regeneration, early studies compared the cell replication
rates of different epithelial strata within the limbus. The
use of mitotic figure counts and thymidine incorporation
assays revealed that the basal cell layer possesses high
proliferative capacity (Buschke et al., 1943; Hanna and
O’Brien, 1960). In addition, the centripetal migration of
the melanin pigment cells located at the corneal periphery
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in both rabbits and humans further implies the presence
of a stem cell source within the limbus (Mann, 1944;
Davanger and Evensen, 1971).
The loss of limbus from various causes leads to a
condition known as limbal stem cell deficiency (LSCD),
which is characterized by corneal neovascularization,
conjunctivalization, and inflammation. Treatment
strategies for LSCD include limbal epithelial stem cell
transplantation. The fate of stem cells after transplantation
remains an unanswered question surrounding this
procedure. There are various reports on stem cell tracking
after transplantation in LSCD such as DNA fingerprinting,
sex mismatch labeling, and green fluorescent protein
labeling. The limitations of the existing literature on
limbal stem cell tracking include short follow-up periods,
the absence of a long-lasting label, ex vivo rather than in
vivo labeling, and experiments restricted to animal models
such as mice, rats, and goats. This review summarizes the
current treatments available for LSCD, the substrates used
during limbal stem cell culture and transplantation, and
findings from posttransplant, cell tracking experiments
conducted up to date.
2. LSCs
The border between the cornea and sclera is known as the
limbus. The corneal limbus contains the palisades of Vogt,
which harbor the limbal stem cell population (Figure 1).
The undulated appearance of the limbal region reflects
the morphology of the palisades of Vogt, a series of fibro
vascular ridges at the corneal periphery that harbor LSCs.
LSCs are localized to the superior and inferior regions of
the limbus, which are protected by upper and lower eyelid
coverage, respectively (Davanger and Evensen, 1971). The
limbal epithelial stem cell hypothesis, described previously,
was derives from the X, Y, Z hypothesis of corneal
epithelial maintenance (Thoft and Friend, 1983). This
model posits that proliferation of the basal cells (X) and
centripetal movement of the peripheral cells (Y) help in
the homeostasis of the cells shed from the corneal surface

(Z). The equation given below explains the hypothesis:
X = proliferation of the basal cells;
Y = the cells from the periphery of the cornea;
Z = the cells shed from the surface;
X+Y=Z
LSCs have the capacity to self-renew, divide, and
differentiate into corneal epithelial cells. As they
differentiate, the stem cells successively transform into early
transient amplifying cells, late transient amplifying cells,
post mitotic cells, and finally into terminally differentiated
cells. The capacity of LSCs to self-renew maintains the
cell population of the limbus, thus preserving its ability to
function as a barrier against encroachment by conjunctiva
cells and vascularization of the cornea. The niche where
LSCs are located helps in the stemness maintenance of the
cells.
2.1. LSC niche
The distinguishing feature of the limbal stem cell niche is
its transparency. The limbus is the only stem cell niche that
can be visualized noninvasively, through slit-lamp and in
vivo confocal microscopy (IVCM), due to its superficial
anatomical location. LSCs are deeply buried within the
basal interpalisade epithelial papillae of the palisades of
Vogt, which in turn are surrounded by melanocytes and
covered by pigmented caps of melanocytes. Findings
from numerous studies suggest that melanocytes protect
LSCs against oxidative DNA damage and ultraviolet
radiation (Goldberg and Bron, 1982; Ljubimov et al.,
1995; Bessou-Touya et al., 1998; Echevarria and Di
Girolamo, 2011). Structurally, the palisades of Vogt
provide extra surface area for the accommodation of a
large number of LSCs, enabling them to communicate
through cell-to-cell, cell-to-extracellular matrix, and
paracrine signaling. The palisades of Vogt are highly
innervated and richly vascularized. Apart from epithelial
stem cells, the limbal niche contains neural crest-derived
cell types such as melanocytes, mesenchymal-like stromal

Figure 1. Palisades of Vogt. A slit lamp examination reveals the limbus-specific feature, the
palisades of Vogt (Oie and Nishida, 2013).
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keratocytes, sensory neurons, vascular endothelial cells,
and Langerhans cells for immune surveillance (Gage et al.,
2005; Yoshida et al., 2006; Hayashi et al., 2007; Li et al.,
2007; Niederer et al., 2007; Li et al., 2012).
Studies of the niche environment in both suspension
and explant ex vivo cultures indicate that the niche plays
a major role in maintaining the health and stemness
of LSCs. In explant cultures the niche is intact and cells
migrate outwards to the leading edge, where they are
activated through cell cycle control mechanisms in the
event of acute injury. In suspension cultures, where the
native niche is destroyed, a heterogeneous population
of cells forms spheres, which act as a make-shift niche
to protect the LSCs in culture (Ksander et al., 2014). In
high melanin containing individuals, stripes resulting
from melanin migration aid in the identification of LSCs
located in the basal cell layer of the limbus. Melanocytes
themselves can be used as a substrate to expand the LSCs
in both 2D and 3D in vitro cultures. The resulting cells are
positive for the expression of putative stem cell markers.
The coculture of limbal epithelial cells and human limbal
melanocytes (hLM) on Real Architecture For 3D Tissue
(RAFT) revealed the formation of multiple epithelial layers
and the preservation of basal cells in an undifferentiated
state, suggesting that melanocytes play a significant role in
stem cell niche regulation (Dziasko et al., 2015).
2.2. LSC marker
Despite the encouraging clinical data on LSC
transplantation, a full biological characterization of LSCs
is still lacking. Moreover, specific markers allowing for
the absolute, prospective identification of LSCs from
adjacent nonstem cells or other progenitor cells have yet
to be identified. Current data suggest that the expression
of biological markers differs between LSCs and other
progenitor cells (early transient amplifying cells, late
transient amplifying cells, postmitotic cells). Key LSC
markers include the extracellular (EC) proteins ABCG2
and Notch-1, and the intracellular (IC) proteins ΔNp63α,
C/EBP-δ, Bmi1, and K15 (Pellegrini et al., 2011). In
contrast, transient amplifying cells possess the EC markers
α9 integrin, β1 integrin, connexin 43, and the IC marker
α-enolase. Limbal basal cells express numerous cytokeratin
proteins including K5, K15, K14, K19, as well as vimentin
(Schlötzer-Schrehardt and Kruse, 2005; Secker and
Daniels, 2009; Notara et al., 2010). Among the markers
mentioned, expression of ABCG2 is not confined to
LSCs, but occurs across limbal basal cells and cytokeratin
proteins K5, K15, K14, and K19 are also expressed by
mature cornea and conjunctiva epithelial cells (Ohyama et
al., 2006; Nubile et al., 2013).
Current research efforts aim to identify a more
comprehensive list of markers characteristic of LSCs and
progenitor cells. For example, the transcription factor of

the Wnt signaling system, TCF-4, has been shown to play
an essential role in LSC maintenance via the survivin,
p63, p57 signaling pathway (Lu et al., 2012). Periostin, a
nonstructural matricellular protein, also called osteoblastspecific factor-2, is expressed only in the basal layer of the
limbal epithelium. Periostin colocalizes with well-known
putative stem/progenitor markers p63, Bmi-1, and TCF4
(Qu et al., 2015). However, periostin has not been found to
colocalize with ΔNp63α.
Other possible LSC markers include primary cilium
expression in the presence of large heterochromatinized
nuclei, as well as stage-specific early embryogenic
antigen-4 and p63α co-expression (Mariappan et al.,
2014). Cytoplasmic expression of the leucine-rich repeatcontaining G-protein-coupled receptor 5 is found in 100%
of cells within the limbal crypt under normal conditions,
and expression decreases in the event of inflammation
(Curcio et al., 2015). Finally, the ATP-binding cassette
subfamily B member 5 (ABCB5) may play an essential
role in limbus function, corneal development, and repair.
ABCB5 colocalizes with p63α and its variant ΔNp63α
in the limbal palisades of Vogt. Label retention assays
involving limbal epithelial cells have shown that ABCB5 is
expressed in the label-retaining cells presumed to be stem
cells (Ksander et al., 2014).
3. LSCD
LSCD is a condition in which the stem cell and barrier
functions of the limbus fail (Ahmad et al., 2010). LSCD
results in painful blinding due to conjunctivalization,
neovascularization, and inflammation of the cornea. The
causes of LSCD are broadly categorized into primary
(hereditary) and secondary (acquired). LSCD can affect
one eye (unilateral) or both eyes (bilateral) and it can be
total or partial (Kolli et al., 2010). Table 1 summarizes the
etiology of LSCD.
3.1. Current treatment procedures for LSCD
Currently there is no universally approved protocol for the
treatment of LSCD. The transplantation procedures listed
in Figure 2 vary with regards to cell source, cell type, and
culture substrate. A large cohort of LSCD patients have
undergone cultivated limbal epithelial transplantation
(CLET), which involves the use of human amniotic
membrane (hAM) as a culture substrate or scaffold
(Sangwan et al., 2011). CLET can occur via two different
culture methods: explant or suspension. Explant culture
requires the placement of individual segments of a limbal
biopsy onto hAM, whereas suspension culture requires
enzymatic or mechanical digestion of biopsy tissue to
isolate a suspension of LSCs for expansion on USFDAapproved, NIH 3T3-J2 feeder cells (Sangwan et al., 2006;
Eslani et al., 2012; Ramachandran et al., 2014). When LSCD
is unilateral, the contralateral (unaffected) eye is used as a
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Table 1. Etiology of limbal stem cell deficiency.
Primary (hereditary)

➢
➢
➢

Aniridia

➢
➢

Secondary (acquired)
Contact lens wear

Ectrodactyly-ectodermal clefting syndrome

➢
➢
➢

keratitis-ichthyosis-deafness syndrome

➢

Systemic diseases like diabetes, graft versus host disease,
rosacea, vitamin A deficiency, etc.

Keratitis associated with multiple endocrine deficiency

dyskeratosis congenita

Chemical or thermal burns
Inflammatory diseases like Stevens–Johnson syndrome,
neurotrophic keratopathy, bullous keratopathy, Mooren
ulcers, etc.

Figure 2. Flowchart for strategies of limbal stem cell transplantation.

cell source. If viable tissue remains despite damage to the
eye, cells can be collected from the ipsilateral (affected)
eye for treatment (Vazirani et al., 2014). However, bilateral
LSCD necessitates an alternative cell source such as oral
mucosal epithelial stem cells, conjunctiva epithelial cells,
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embryonic stem cells, dental pulp stem cells, mesenchymal
stem cells from bone marrow, umbilical cord stem cells,
or hair follicle stem cells (Homma et al., 2004; Nakamura
et al., 2004; Ono et al., 2007; Ang et al., 2010; Gomes et
al., 2010; Meyer‐Blazejewska et al., 2011; Reza et al., 2011).

KACHAM et al. / Turk J Biol
The stem cell-based treatment procedures for LSCD have
been reviewed by Sevim and Acar (2013).
There are multiple substrates or scaffolds that can
be used for the cultivation and transplantation of LSCs
(Table 2). Currently, the preferred scaffolds or substrates
for limbal stem cell cultivation are the hAM and fibrin
gels. The hAM is favored because it provides the stromal
network needed for epithelial cells (Malak et al., 1993),
secretes essential growth factors (Koizumi et al., 2000), and
is less immunogenic (Akle et al., 1981; Adinolfi et al., 1985;
Houlihan et al., 1995). Despite having these advantages,
the amniotic membrane preparation is a tedious and
costly process. These factors encouraged research on other
substrates that can be easily prepared in cost effective ways.
Despite the different culture methods and substrates,
the success rate of LSC transplantation decreases as the
follow-up period increases. The exact mechanism of
how the transplanted cells help in curing LSCD is still
unknown. There are three possible mechanisms of healing
by LSC transplantation:
I. The transplanted stem cells migrate to reach the
palisades of Vogt or limbal crypts in the wounded eye.
II. The transplanted stem cells or heterogeneous cell
population are able to salvage and activate remaining stem
cells in the damaged eye of the recipient.
III. The transplanted stem cells receive and transmit
wound-healing signals from the surrounding environment
and are fully eradicated after some time. Only recipient
stem cells help in the maintenance of corneal homeostasis.
3.2. Need for the labeling and tracking of LSCs
Controversy surrounds the mechanism by which
transplanted LSCs repair damage to the cornea. Detailed in
vivo studies are needed to monitor the fate of transplanted
cells, including their distribution, differentiation, and
longevity over time. Previous studies have attempted
to label and track the activity of LSCs in the transplant
environment. However, due to limitations in current

labeling techniques, these experiments did not implicate
a definitive mechanism by which the cells facilitate wound
repair. Thus, there is a pressing need for the development
of a more optimal label for long term monitoring, and
particularly one that can be imaged noninvasively in both
in vivo and in vitro conditions.
Accurate labeling and tracking of transplanted LSCs
for an extended period will elucidate the stem cell homing
patterns and reveal any changes in cell properties that occur
in the recipient. Effectively addressing these questions will
require the coupling of enhanced labeling and tracking
techniques with a more detailed understanding of LSCD
models involving varying degrees of damage, i.e. partial or
focal, total, unilateral, or bilateral.
4. LSC labeling and tracking
Clinical and impression cytology findings were used
as a grading system to measure the severity of LSCD
before and after the transplant procedure. Impression
cytology, however, is invasive to the eye. Thus, there is
a need for another method to assess the efficacy of LSC
transplantation. IVCM may be a suitable alternative;
studies have shown that IVCM and impression cytology
analysis of ex vivo cultured limbal stem cell transplant
procedures yield comparable results.
A study involving 6-month and 1-year follow-up
of keratolimbal allografts have shown that IVCM is a
useful tool for monitoring cell density and diagnosing
graft failure (Hong et al., 2011). Furthermore, IVCM can
differentiate corneal cells from conjunctival cells based
on morphological and physiological characteristics and
it can demarcate the corneal-to-conjunctival epithelial
transition in vivo (Pedrotti et al., 2015). Neither of these
studies provides evidence supporting the reformation of
the native limbal niche within the palisades of Vogt after
transplantation. Limitations of IVCM include the inability
to distinguish stem cells from the larger cell population,

Table 2. Summary of substrates used in LSCD treatment.
S. No.

Substrate

Application

1

Human amniotic membrane (Schwab et al., 2000; Tsai et al., 2000; Sangwan et al., 2003)

Clinical

2

Fibrin (Rama et al., 2001)

Clinical

3

Soft contact lens (Di Girolamo et al., 2009)

Clinical

4

Corneal stroma (Espana et al., 2003)

Research

5

PNIPAAm grafted surface (Nishida et al., 2004)

Research

6

Recombinant human collagen hydrogel (Dravida et al., 2008)

Research

7

Silk fibroin (Chirila et al., 2008; Lawrence et al., 2008)

Research

8

Nanofiber scaffold (Zajicova et al., 2010)

Research
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and donor cells from recipient cells. The employment of
labeling techniques, for example green fluorescent protein
tagging, would aid in the identification and tracking of
stem cells during IVCM (Shortt et al., 2008).
Stem cell labeling can be indirect or direct. Indirect
labeling involves the genetic modification of cells to
incorporate the reporter gene with selective expression. By
this method, labeled cells can be traced over the long term
due to the stable transfection of cells with the reporter
gene. Direct labeling requires staining or tagging cells with
dyes, fluorochromes, or fluorophores. Although direct
labeling is a far less tedious method, it cannot effectively
track cells in vivo. Indirect labeling is more suited for in
vivo tracking, but the genetic modification requirements
make it an impractical technique for use in humans.
Most tracking studies have been conducted in allogeneic
transplants (allotransplantation). One allotransplantation
study used impression cytology and DNA fingerprinting
analysis to determine the fate of transplanted cells and the
nature of the cells directly responsible for wound healing
during long term follow-up (Henderson et al., 2001a).
Follow-up using DNA fingerprinting analysis shows that
superficial corneal epithelial cells are those of the recipient
rather than the donor, meaning that the transplanted cells
are not directly repopulating the damaged epithelium
(Henderson et al., 2001b). However, in this case the tracking
method used was only able to indicate the origin of the cells,
not the mechanism by which the regeneration of the cornea
occurred. In a different study, involving sex mismatch limbal
allograft transplantation, X, Y chromosome analysis and
HLA origin analysis suggested that there is a broad range
of cell spectrum in the cell origin (Shimazaki et al., 1999).
Impression cytology analysis, performed on patients who
underwent cultured limbal epithelial allotransplantation,
shows that the donor cells were no longer detectable after 9
months (Daya et al., 2005).
Labeling goat LSCs using the p-Venus vector carrying
green fluorescent protein is a new method to track cells
after autologous transplantation (autotransplantation) in
vitro and in vivo. Venus labeling of cells has shown that
donor cells remained in the superficial corneal epithelium
for 3 months after transplant, rather than penetrating
into the suprabasal or basal layers (Yin et al., 2013). This
finding indicates that the transplanted LSCs are not able
to reach their native location, the basement membrane,
which is well-protected. The short follow-up period and
mere single-confirmation of green fluorescent protein
expression by polymerase chain reaction may have
influenced these results.
Quantum dot labeling has also been utilized to track
limbal epithelial cells in vivo. Recent experiments suggest
that quantum dots are nontoxic and do not affect cell
proliferation or differentiation (Genicio et al., 2015).

1064

However, tracking in this study was conducted for a
period of only two weeks, and in rabbit rather than human
corneas. Nevertheless, standardization of a protocol for
quantum dot labeling in human limbal cells is currently
underway, as well as for clinical imaging techniques to
track the cells. The role of transplanted cells in the long
term maintenance of the corneal epithelium through
engraftment, positioning, division, movement, and
differentiation was not determined in this recent study (Di
Girolamo, 2015). Therefore, an urgent need remains for
new imaging techniques or combinatorial approaches to
tracking human LSCs in vivo to improve the success rate
of stem cell transplantation.
5. Conclusion
Limbal stem cell transplantation represents the current
best practice for LSCD treatment. Yet, LSC transplant
procedures have been only able to cure the disease
temporarily, not permanently. Proper biological
characterization of LSCs, clarification of the role of the
limbal microenvironment, and determination of the fate
of LSCs following transplantation are critical to improving
the quality and efficacy of LSCD treatment. Currently, there
is no “perfect” marker for limbal stem cell identification,
which is one principal reason for the shortage of tracking
studies, the other being the inadequacy of current labeling
methods. The recently identified marker, ABCB5, may
enable future studies on LSC tracking after transplantation.
Multicolor lineage labeling methods and cell tracking
techniques used in other human tissues will also be
advantageous to this end. Further studies are inevitably
needed to elucidate the mechanism of corneal healing after
stem cell transplantation.
The long term efficacy of limbal stem cell transplantation
depends upon the isolation and maintenance of the stem
and niche cells for grafting in an organized 3D scaffold
or substrate. In order to track cell fate in vivo, labeling
techniques employing harmless genetic modification and
fluorescent reporter protein expression would be preferred.
The long term, stable expression of a fluorescence reporter
in transplanted LSCs may be the key to elucidating
the mechanisms behind corneal regeneration in LSCD
patients. Successful methods for tracking stem cells
in other parts of the human body may be applied to
LSC tracking after transplantation. Fluorescein iso
thiocyanate conjugated mesoporous silica nanoparticle
labeling (Huang et al., 2005), cholera toxin B conjugated
quantum dot (CTB-QD) labeling (Villa et al., 2010) and
bioluminescence imaging (Huang et al., 2012) represent a
few of these potential techniques. Moreover, technological
advances enabling lineage tracing and single cell analyses
in hematopoietic stem cells may also be applicable to LSCs
(Nimmo et al., 2015).
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